Drugs / Levobupivicaine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00830089 | Sep 2009 → Sep 2011 | — | University of Nottingham | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01291147 Comparator | Feb 2011 → Feb 2012 | — | Ashford and St. Peter's Hospitals NHS Trust | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02556970 Background | ? → Sep 2015 | — | University Hospitals Bristol and Weston NHS Foundation Trust | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levobupivicaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01291147 ↗ |
| Route | Other | “injected into the transversus abdominis plane (TAP) under ultrasound guidance” NCT00830089 ↗ |